Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
36,622,682
-
Share change
-
+1,453,256
-
Total reported value
-
$355,897,814
-
Put/Call ratio
-
76%
-
Price per share
-
$9.72
-
Number of holders
-
117
-
Value change
-
+$13,747,740
-
Number of buys
-
55
-
Number of sells
-
54
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q1 2021
As of 31 Mar 2021,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,622,682 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FRED ALGER MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Camber Capital Management LP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Palo Alto Investors LP, GREAT POINT PARTNERS LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.